H. I. Joller-Jemelka

Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen.

H. Joller-jemelka, P. Byers, A. Superti-Furga, 1989, American journal of medical genetics.

Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA

H. Joller-jemelka, R. Dummer, G. Burg, 1996, Archives of Dermatological Research.

Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans.

V. Hans, M. Morganti-Kossmann, T. Kossmann, 2001, Journal of neurotrauma.

Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.

H. Joller-jemelka, L. Truedsson, C. Hack, 2008, Journal of immunological methods.